+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Infertility (Testing and Treatment) Market 2019-2027

  • ID: 4774255
  • Report
  • Region: Global
  • 195 pages
  • Triton Market Research
UP TO OFF
until Jan 31st 2020
1 of 3

FEATURED COMPANIES

  • Andrology Solutions
  • Esco Micro Pte. Ltd.
  • Genea
  • Irvine Scientific
  • Origio
  • Progyny
  • MORE
Market Outlook

The global infertility (testing and treatment) market is expected to progress at a CAGR of 7.14% over the forecast duration 2019-2027.

The WHO statistics have shown that out of every six couples, at least one of them suffers from infertility issues worldwide. Rise in the medical tourism for infertility treatments, a more convenient surrogacy law and various initiatives for creating awareness of infertility treatments are driving the growth of the market globally. Also, the rising pollution levels have led to growing infertility, which is further boosting the market demand for infertility (testing and treatment) devices globally. However, the market is facing challenges from traditional infertility treatments. Also, these testing and treatment concerning infertility issues are considered to be a taboo in society, especially amongst men.

The infertility (testing and treatment) market is segmented into male, female and end-user segments. The end-user segment is divided into fertility & surgical centers, hospitals & research laboratories and cryobanks. The male segment is divided into two substituents, the male infertility testing and male infertility treatment. The male infertility treatment segment is classified into sperm retrieval treatment, intracytoplasmic sperm injection (ICSI), microsurgical sperm aspiration (MESA), in-vitro fertilization (IVF), intrauterine insemination (IUI), assisted reproductive technique (ART), varicocele repairs, testicular sperm extraction (TESE), vasovasostomy and vasoepididymostomy (vasectomy reversal). The male infertility testing segment is divided into sperm penetration assay, microscopic examination, computer-assisted semen analysis (CASA), sperm agglutination, oxidative stress analysis, DNA fragmentation and others.

Regional Outlook

The infertility (testing and treatment) market are segmented into regions such as Europe, Latin America, North America, Middle East & Africa and the Asia-Pacific. The North America region is expected to grow at a steady rate as women in this region prefer to have pregnancies at an older age, thus leading to high chances of infertility. Also, IVF treatment costs are economical. The European region is currently dominating the infertility market mainly due to high diagnostics rates, public awareness and high disposable incomes of the population. The Asia-Pacific region is progressing at the highest growth rate in the forecast period, owing to the huge investments by various governments in the pharmaceutical industries and healthcare centers.

Competitive Outlook

The key players in the global infertility (testing and treatment) market are Esco Micro Pte. Ltd., Irvine Scientific, Endo Pharmaceuticals, Thermo Fisher Scientific Inc., Origio, OvaScience, Genea, Halotech DNA, Vitrolife AB, Merck, Quest Diagnostic, Ferring Pharmaceuticals, Andrology Solutions, The Cooper Companies, Inc. and Progyny.

Progyny, Inc. is a US-based healthcare company that provides fertility services to consumers and employers. It provides a non-invasive time-lapse imaging system to aid in early embryo selection; a no-restriction IVF package plan for patients; egg freezing options through its network of fertility doctors across the United States; and a patient-matching technology platform for the fertility industry. The company entered into a strategic alliance with Mercer L.L.C. in January 2017 to provide employers and their employees with an innovative fertility benefit product that will help organizations to considerably cut down on NICU and associated high-risk maternity-related costs while increasing access and positive outcomes.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Andrology Solutions
  • Esco Micro Pte. Ltd.
  • Genea
  • Irvine Scientific
  • Origio
  • Progyny
  • MORE
1. Infertility (Testing And Treatment) Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Key Insights
2.2.1. Ivf Dominates the Female Treatment Market
2.2.2. Oxidative Stress Analysis is the Fastest Growing Male Infertility Testing Market
2.3. Porter’s Five Force Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute
2.3.3. Bargaining Power of Buyers
2.3.4. Bargaining Power of Suppliers
2.3.5. Intensity of Competitive Rivalry
2.4. Key Impact Analysis
2.4.1. Treatment Options
2.4.2. Quality of Medical Procedures
2.4.3. Price of Treatments
2.4.4. Shift Towards Medical Tourism
2.4.5. Reimbursement
2.5. Market Attractiveness Index
2.6. Vendor Scorecard
2.7. Industry Components
2.7.1. Raw Material Procurement
2.7.2. Manufacturing
2.7.3. Supply LoGIStics
2.7.4. Distribution Channels
2.7.5. End-Users
2.8. Regulatory Framework
2.9. Market Drivers
2.9.1. Rise in Infertility And Treatment Awareness
2.9.2. Medical Tourism in Fertility Treatments
2.9.3. Surrogacy Laws Are Getting More Defined
2.9.4. Healthcare Advances Have Fine-Tuned Fertility Treatment
2.9.5. Increasing Effectiveness of Treatments
2.9.6. Healthier Donor Eggs
2.9.7. Introduction of New Testing Devices
2.10. Market Restraints
2.10.1. Treatment Procedure Out of Reach For Many Due to High Costs
2.10.2. Country-Wise Regulatory Issues
2.11. Market Opportunities
2.11.1. Reducing the Cost of Treatment to Make It More Accessible
2.11.2. Ivf Attracting Investments From Private Equity Investors
2.11.3. Diy Testing Increasing Access And Reducing Cost
2.12. Market Challenges
2.12.1. Infertility Considered a Social Taboo Amongst Men
2.12.2. Perils of Multiple Pregnancies
2.12.3. Traditional Treatments Used Widely As An Alternative For Infertility Treatments

3. Infertility (Testing And Treatment) Market Outlook - By Gender
3.1. Male Gender
3.1.1. Testing
3.1.1.1. Dna Fragmentation
3.1.1.2. Oxidative Stress Analysis
3.1.1.3. Sperm Penetration Assay
3.1.1.4. Computer-Assisted Semen Analysis (Casa)
3.1.1.5. Sperm Agglutination
3.1.1.6. Microscopic Examination
3.1.1.7. Others
3.1.2. Treatment
3.1.2.1. Vasovasostomy And Vasoepididymostomy (Vasectomy Reversal)
3.1.2.2. Sperm Retrieval Treatment
3.1.2.3. Microsurgical Sperm Aspiration (Mesa)
3.1.2.4. Testicular Sperm Extraction (Tese)
3.1.2.5. Varicocele Repairs
3.1.2.6. Assisted Reproductive Techniques (Art)
3.1.2.7. Intrauterine Insemination (Iui)
3.1.2.8. In-Vitro Fertilization (Ivf)
3.1.2.9. Intracytoplasmic Sperm Injection (Icsi)
3.2. Female Gender
3.2.1. Female Infertility Testing
3.2.1.1. Ovulation Testing
3.2.1.2. Hysterosalpingography
3.2.1.3. Laparoscopy
3.2.1.4. Transvaginal Ultrasound
3.2.1.5. Ovarian Reserve Testing
3.2.1.6. Hormonal Level Testing
3.2.1.7. Others
3.2.2. Treatment
3.2.2.1. In-Vitro Fertilization
3.2.2.2. Intrauterine Insemination (Iui)
3.2.2.3. Drug And Hormone Therapies

4. Infertility (Testing And Treatment) Market Outlook - By End-Use
4.1. Fertility Clinics
4.2. Hospitals
4.3. Surgical Centers
4.4. Clinical Research Institutes

5. Infertility (Testing And Treatment) Market - Regional Outlook
5.1. North America
5.1.1. Market By Gender
5.1.1.1. Market By Male Gender
5.1.1.1.1. Market By Male Infertility Testing
5.1.1.2. Market By Female Gender
5.1.1.2.1. Market By Female Infertility Testing
5.1.2. Market By End-Use
5.1.3. Country Analysis
5.1.3.1. United States
5.1.3.2. Canada
5.2. Europe
5.2.1. Market By Gender
5.2.1.1. Market By Male Gender
5.2.1.1.1. Market By Male Infertility Testing
5.2.1.2. Market By Female Gender
5.2.1.2.1. Market By Female Infertility Testing
5.2.2. Market By End-Use
5.2.3. Country Analysis
5.2.3.1. United Kingdom
5.2.3.2. Germany
5.2.3.3. France
5.2.3.4. Spain
5.2.3.5. Italy
5.2.3.6. Russia
5.2.3.7. Rest of Europe
5.3. Asia-Pacific
5.3.1. Market By Gender
5.3.1.1. Market By Male Gender
5.3.1.1.1. Market By Male Infertility Testing
5.3.1.2. Market By Female Gender
5.3.1.2.1. Market By Female Infertility Testing
5.3.2. Market By End-Use
5.3.3. Country Analysis
5.3.3.1. China
5.3.3.2. Japan
5.3.3.3. India
5.3.3.4. South Korea
5.3.3.5. Asean Countries
5.3.3.6. Australia & New Zealand
5.3.3.7. Rest of Asia-Pacific
5.4. Latin America
5.4.1. Market By Gender
5.4.1.1. Market By Male Gender
5.4.1.1.1. Market By Male Infertility Testing
5.4.1.2. Market By Female Gender
5.4.1.2.1. Market By Female Infertility Testing
5.4.2. Market By End-Use
5.4.3. Country Analysis
5.4.3.1. Brazil
5.4.3.2. Mexico
5.4.3.3. Rest of Latin America
5.5. Middle East & Africa
5.5.1. Market By Gender
5.5.1.1. Market By Male Gender
5.5.1.1.1. Market By Male Infertility Testing
5.5.1.2. Market By Female Gender
5.5.1.2.1. Market By Female Infertility Testing
5.5.2. Market By End-Use
5.5.3. Country Analysis
5.5.3.1. United Arab Emirates
5.5.3.2. Turkey
5.5.3.3. Saudi Arabia
5.5.3.4. South Africa
5.5.3.5. Rest of Middle East & Africa

6. Competitive Landscape
6.1. Andrology Solutions
6.2. Endo Pharmaceuticals
6.3. Progyny
6.4. Ferring Pharmaceuticals
6.5. Genea
6.6. Halotech Dna
6.7. Irvine Scientific
6.8. Merck
6.9. Origio
6.10. Ovascience
6.11. Vitrolife Ab
6.12. Thermo Fisher Scientific, Inc.
6.13. the Cooper Companies, Inc.
6.14. Quest Diagnostic
6.15. Esco Micro Pte. Ltd.

7. Research Methodology & Scope
7.1. Research Scope & Deliverables
7.1.1. Objectives of Study
7.2. Sources of Data
7.2.1. Primary Data Sources
7.2.2. Secondary Data Sources
7.3. Research Methodology
7.3.1. Evaluation of Proposed Market
7.3.2. Identification of Data Sources
7.3.3. Assessment of Market Determinants
7.3.4. Data Collection
7.3.5. Data Validation & Analysis

List of Tables
Table 1: Global Infertility (Testing And Treatment) Market, By Geography, 2019-2027 (In $ Million)
Table 2: Market Attractiveness Index
Table 3: Vendor Scorecard
Table 4: Regulatory Framework
Table 5: Average Cost Comparison of Infertility Treatments
Table 6: Global Infertility (Testing And Treatment) Market, By Gender, 2019-2027, (In $ Million)
Table 7: Global Infertility (Testing And Treatment) Market, By Male Gender, 2019-2027, (In $ Million)
Table 8: Global Infertility (Testing And Treatment) Market, By Male Infertility Testing, 2019-2027, (In $ Million)
Table 9: Pros And Cons of Dna Sharing Methods
Table 10: Global Infertility (Testing And Treatment) Market, By Female Gender, 2019-2027, (In $ Million)
Table 11: Global Infertility (Testing And Treatment) Market, By Female Infertility Testing, 2019-2027, (In $ Million)
Table 12: Cost of Ovulation Testing Kits in the Us
Table 13: Cost of Hormonal Test in the Us
Table 14: Average Cost of Some Infertility Treatments
Table 15: Some Common Drug Therapies
Table 16: Global Infertility (Testing And Treatment) Market, By End-Use, 2019-2027, (In $ Million)
Table 17: Global Infertility (Testing And Treatment) Market, By Geography, 2019-2027, (In $ Million)
Table 18: North America Infertility (Testing And Treatment) Market, By Country, 2019-2027 (In $ Million)
Table 19: North America Infertility (Testing And Treatment) Market, By Gender, 2019-2027 (In $ Million)
Table 20: North America Infertility (Testing And Treatment) Market, By End-Use, 2019-2027 (In $ Million)
Table 21: North America Infertility (Testing And Treatment) Market, By Male Infertility Testing, 2019-2027 (In $ Million)
Table 22: North America Infertility (Testing And Treatment) Market, By Female Gender, 2019-2027 (In $ Million)
Table 23: North America Infertility (Testing And Treatment) Market, By Female Infertility Testing, 2019-2027 (In $ Million)
Table 24: North America Infertility (Testing And Treatment) Market, By Gender, 2019-2027 (In $ Million)
Table 25: Success of Assisted Reproductive Technology (Art) Using Donor Eggs in the Us in 2013
Table 26: Costs For Infertility Treatments in the Us 2015
Table 27: Cost of Ivf & Icsi Treatment, Canada 2014
Table 28: Europe Infertility (Testing And Treatment) Market, By Country, 2019-2027 (In $ Million)
Table 29: Europe Infertility (Testing And Treatment) Market, By Gender, 2019-2027 (In $ Million)
Table 30: Europe Infertility (Testing And Treatment) Market, By Male Gender, 2019-2027 (In $ Million)
Table 31: Europe Infertility (Testing And Treatment) Market, By Male Infertility Testing, 2019-2027 (In $ Million)
Table 32: Europe Infertility (Testing And Treatment) Market, By Female Gender, 2019-2027 (In $ Million)
Table 33: Europe Infertility (Testing And Treatment) Market, By Female Infertility Testing, 2019-2027 (In $ Million)
Table 34: Europe Infertility (Testing And Treatment) Market, By End-Use, 2019-2027 (In $ Million)
Table 35: Cost of Ivf in Russia
Table 36: Asia-Pacific Infertility (Testing And Treatment) Market, By Country, 2019-2027 (In $ Million)
Table 37: Growth in Ivf Clinics in Asia
Table 38: Asia-Pacific Infertility (Testing And Treatment) Market, By Gender, 2019-2027 (In $ Million)
Table 39: Asia-Pacific Infertility (Testing And Treatment) Market, By Male Gender, 2019-2027 (In $ Million)
Table 40: Asia-Pacific Infertility (Testing And Treatment) Market, By Male Infertility Testing, 2019-2027 (In $ Million)
Table 41: Asia-Pacific Infertility (Testing And Treatment) Market, By Female Gender, 2019-2027 (In $ Million)
Table 42: Asia-Pacific Infertility (Testing And Treatment) Market, By Female Infertility Testing, 2019-2027 (In $ Million)
Table 43: Asia-Pacific Infertility (Testing And Treatment) Market, By End-Use, 2019-2027 (In $ Million)
Table 44: Medical Tourism in South Korea ($ Million)
Table 45: Latin America Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Table 46: Latin America Infertility (Testing And Treatment) Market, By Gender, 2019-2027 (In $ Million)
Table 47: Latin America Infertility (Testing And Treatment) Market, By Male Gender, 2019-2027 (In $ Million)
Table 48: Latin America Infertility (Testing And Treatment) Market, By Male Infertility Testing, 2019-2027 (In $ Million)
Table 49: Latin America Infertility (Testing And Treatment) Market, By Female Gender, 2019-2027 (In $ Million)
Table 50: Latin America Infertility (Testing And Treatment) Market, By Female Infertility Testing, 2019-2027 (In $ Million)
Table 51: Latin America Infertility (Testing And Treatment) Market, By End-Use, 2019-2027 (In $ Million)
Table 52: Middle East & Africa Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Table 53: Middle East & Africa Infertility (Testing And Treatment) Market, By Gender, 2019-2027 (In $ Million)
Table 54: Middle East & Africa Infertility (Testing And Treatment) Market, By Male Gender, 2019-2027 (In $ Million)
Table 55: Middle East & Africa Infertility (Testing And Treatment) Market, By Male Infertility Testing, 2019-2027 (In $ Million)
Table 56: Middle East & Africa Infertility (Testing And Treatment) Market, By Female Gender, 2019-2027 (In $ Million)
Table 57: Middle East & Africa Infertility (Testing And Treatment) Market, By Female Infertility Testing, 2019-2027 (In $ Million)
Table 58: Middle East & Africa Infertility (Testing And Treatment) Market, By End-Use, 2019-2027 (In $ Million)

List of Figures
Figure 1: Global Infertility (Testing And Treatment) Market, By End-User, 2018 & 2027 (In %)
Figure 2: Porter’s Five Force Analysis
Figure 3: Key Buying Impact Analysis
Figure 4: Industry Components
Figure 5: Major Fertility Treatment Destination Ranking
Figure 6: Clinical Algorithm For the Evaluation of Infertile Woman
Figure 7: Rate of Multiple Deliveries
Figure 8: Global Infertility (Testing And Treatment) Market, By Male Gender, 2019-2027 (In $ Million)
Figure 9: Global Infertility (Testing And Treatment) Market, By Testing, 2019-2027 (In $ Million)
Figure 10: Global Infertility (Testing And Treatment) Market, By Dna Fragmentation, 2019-2027 (In $ Million)
Figure 11: Causes of Sperm Dna Fragmentation
Figure 12: Global Infertility (Testing And Treatment) Market, By Oxidative Stress Analysis, 2019-2027 (In $ Million)
Figure 13: Global Infertility (Testing And Treatment) Market, By Sperm Penetration Assay, 2019-2027 (In $ Million)
Figure 14: Global Infertility (Testing And Treatment) Market, By Computer-Assisted Semen Analysis, 2019-2027 (In $ Million)
Figure 15: Global Infertility (Testing And Treatment) Market, By Sperm Agglutination, 2019-2027 (In $ Million)
Figure 16: Global Infertility (Testing And Treatment) Market, By Microscopic Examination, 2019-2027 (In $ Million)
Figure 17: Global Infertility (Testing And Treatment) Market, By Others, 2019-2027 (In $ Million)
Figure 18: Global Infertility (Testing And Treatment) Market, By Treatment, 2019-2027 (In $ Million)
Figure 19: Global Infertility (Testing And Treatment) Market, By Female Gender, 2019-2027 (In $ Million)
Figure 20: Global Infertility (Testing And Treatment) Market, By Female Infertility Testing, 2019-2027 (In $ Million)
Figure 21: Global Infertility (Testing And Treatment) Market, By Ovulation Testing, 2019-2027 (In $ Million)
Figure 22: Global Infertility (Testing And Treatment) Market, By Hysterosalpingography, 2019-2027 (In $ Million)
Figure 23: Global Infertility (Testing And Treatment) Market, By Laparoscopy, 2019-2027 (In $ Million)
Figure 24: Global Infertility (Testing And Treatment) Market, By Transvaginal Ultrasound, 2019-2027 (In $ Million)
Figure 25: Global Infertility (Testing And Treatment) Market, By Ovarian Reserve Testing, 2019-2027 (In $ Million)
Figure 26: Global Infertility (Testing And Treatment) Market, By Hormonal Level Testing, 2019-2027 (In $ Million)
Figure 27: Global Infertility (Testing And Treatment) Market, By Others, 2019-2027 (In $ Million)
Figure 28: Global Infertility (Testing And Treatment) Market, By Female Infertility Treatment, 2019-2027 (In $ Million)
Figure 29: Global Infertility (Testing And Treatment) Market, By Fertility Clinics, 2019-2027 (In $ Million)
Figure 30: Global Infertility (Testing And Treatment) Market, By Hospitals, 2019-2027 (In $ Million)
Figure 31: Global Infertility (Testing And Treatment) Market, By Surgical Centers, 2019-2027 (In $ Million)
Figure 32: Global Infertility (Testing And Treatment) Market, By Clinical Research Institutes, 2019-2027 (In $ Million)
Figure 33: Global Infertility (Testing And Treatment) Market, Regional Outlook, 2018 & 2027 (In %)
Figure 34: United States Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 35: Canada Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 36: United Kingdom Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 37: Fertility Treatment in 2014
Figure 38: Germany Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 39: France Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 40: Spain Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 41: Italy Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 42: Russia Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 43: Rest of Europe Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 44: China Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 45: Japan Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 46: India Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 47: South Korea Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 48: Asean Countries Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 49: Australia & New Zealand Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 50: Rest of Asia-Pacific Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 51: Brazil Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 52: Mexico Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 53: Rest of Latin America Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 54: United Arab Emirates Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 55: Turkey Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 56: Saudi Arabia Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 57: South Africa Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 58: Rest of Middle East & Africa Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Andrology Solutions
  • Endo Pharmaceuticals
  • Progyny
  • Ferring Pharmaceuticals
  • Genea
  • Halotech Dna
  • Irvine Scientific
  • Merck
  • Origio
  • Ovascience
  • Vitrolife AB
  • Thermo Fisher Scientific, Inc.
  • The Cooper Companies, Inc.
  • Quest Diagnostic
  • Esco Micro Pte. Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll